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Lentiviral vectors (LVs) are powerful tools for transgene expression in vivo and in vitro. However, the
construction of LVs is of low efficiency, due to the large sizes and lack of proper clone sites. Therefore, it is
critical to develop efficient strategies for cloning LVs. Here, we reported a combinatorial strategy to
efficiently construct LVs using EGFP, hPlk2 wild type (WT) and mutant genes as inserts. Firstly,
site-directed mutagenesis (SDM) was performed to create BamH I site for the inserts; secondly, pWPI LV
was dephosphorylated after BamH I digestion; finally, the amounts and ratios of the insert and vector DNA
were optimized to increase monomeric ligation. Our results showed that the total percentage of positive
clones was approximately 48%67.6%. Using this method, almost all the vectors could be constructed
through two or three minipreps. Therefore, our study provided an efficient method for constructing
large-size vectors.
L
entiviral vectors (LVs) are powerful tools for gene transduction in vitro and in vivo, because of the following
advantages.Firstly,LVscantransducenotonlymitoticallyactivecells,butalsoslowlydividingcells,andeven
non-dividing terminally differentiated cells
1–4. Secondly, transgenes delivered by LVs are more resistant to
transcriptionalsilencing, whereas,itisacommon phenomenonassociatedwithretroviralvectortransducedcells
after prolonged in vitro or in vivo transplantation
2–4. In addition, LVs can accommodate the use of various
ubiquitous or tissue-specific transcriptional promoters
3,5. Furthermore, the self-inactivating safety modification
of LVs, which permanently disables the viral promoter within the viral long-terminal repeat after integration,
enables transgene expression in the targeted cells to be controlled solely by internal promoters
3,6. Finally, self-
inactivatingmodificationofLVsdoesnotreduceviraltiterssignificantly
6.TheseadvantagesmakeLVsapowerful
tool for stable gene transfer and expression
7–9.
However, it can be highly challenging to clone genes of interest into the third-generation bicistronic lentiviral
transfervectors(LVs),duetotheirlargesizesandlimitedclonesites,therefore,itisimportanttodevelopefficient
strategiesforLVcloning.Classically,twodifferentmatchedsitesareusedtodirectlyclonetheinsertsintovectors
by ligation and transformation
10. Because of the limited clone sites, this strategy is not always applicable for LV
cloning. To create matched clone sites, the incorporation of restriction sites into the primers used for PCR is the
most common strategy, but this method decreases ligation efficiencies due to the inability of some restriction
endonucleasestocleavesitesefficientlyneartheterminiofDNAmolecules
10–13.Anotherstrategyistocreateblunt
ends for the vectors and/or inserts with the Klenow fragment of DNA Polymerase I or T4 DNA Polymerase, but
this method can generate recessed ends due to their 3’–5’ exonuclease activity
14. As a result, the efficiencies of
subsequent ligation and transformation are also significantly decreased. SDM was first established at 1978 by
Hutchisonetal.,anditisessentialingenefunctionalstudies,geneticengineering,proteinengineering,andvector
modifications
15–17. Currently, the QuikChange
TM SDM System developed by Stratagene is a commonly used kit
for mutagenesis using plasmid double-stranded DNA as templates. The advantage of this strategy is that the
products after mutagenesis are circular, double-stranded DNA. After restriction endonuclease digestion and
purification by Agarose gel electrophoresis, theoretically, 100% of the linearized DNA fragments will have
correct-digested ends. Therefore, maximal ligation efficiency can be achieved.
To our knowledge, there are no reports to date on how to efficiently construct LVs with restriction-dependent
cloning strategies. The aim of this study is to create a combinatorial method to efficiently construct LVs. The
strategy described herein is also suitable for constructing other vectors. In order to investigate the relationship
between human polo-like kinase 2 (hPlk2) expression and a-synuclein phosphorylation in vitro
26, we adopted a
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cassette for the expression of dual genes, to construct LVs of hPlk2
WT and mutants, K111M, T239D, T239V, and enhanced fluor-
escence protein gene (EGFP), respectively. The size of the pWPI
vector is about 11.4 kb, and there is a unique BamH I clone site
within the vector. Here, we report a combinatorial method, which
includes insertion of BamH I sites at the 3’-ends of hPlk2 and EGFP
by SDM, dephosphorylating the vector DNA after BamH I digestion
by calf intestinal phosphatase (CIP) treatment, optimizing the
amounts and ratios of the insert and vector DNA, and using
Top10 competent cells for transformation. With this approach, we
successfully constructed five LVs, and the percentages of positive
clones containing EGFP, hPlk2 WT, K111M, T239D, and T239V
inserts, were 37%612.4%, 43%616.6%, 52%6
21.2%, 54%69.8%, and 54%612.8%, respectively. This study pro-
vides an important quantitative method for efficient construction of
LVs.
Results
BamH I site insertion and mutagenesis of hPlk2 mutants. SDM
was performed by PCR, and the parent template DNA was digested
with Dpn I. Different annealing temperatures were used for
pcDNA3.1 BamH I insertion and hPlk2 mutagenesis, representing
approximately Tm25uC, Tm*12uC, and Tm*25uC (Figure 1,
Table 1, 2 and 3), respectively. After transformation and iden-
tification by sequencing, we found that, when lower annealing
temperatures (approximately Tm*25uC) were adopted, more co-
lonies could be obtained, and the mutagenesis efficiencies were
approximately 90% for pcDNA3.1/hPlk2/BamH I insertion, 50%
for K111M mutagenesis, 60% for T239D and 90% for T239V
mutagenesis, respectively (Table 1, 2). Whereas, when higher an-
nealing temperatures (approximately Tm25uC) were used, no
colonies were obtained (Table 1, 3). Interestingly, when the mu-
tagenesis reactions were annealed at Tm*12uC, a few colonies
were obtained after transformation. The mutagenesis efficiencies
were 100% (Table 1, 3). These data suggested that lower annealing
temperatures were more efficient for BamH I insertion, and hPlk2
mutagenesis. However, higher annealing temperatures resulted in
decreased transformation colonies (Table 1, 2 and 3). Our results
were in accord with another report that the annealing tempera-
tures should be determined empirically case by case
10. Although
the Stratagene protocol suggested that the primer pairs should be
of 25,45 bases in length with melting temperature (Tm)$78uC, our
experiments showed that correct mutagenesis was achieved with
longer primers (up to 56 bases). The mutations were ranged from
2 to 6 bases (Table 1). DH5a competent cells were also used for
transformations, but no positive clones were obtained after se-
quencing (data not shown). Therefore, for low efficiency mutagenesis,
Figure 1 | SchematicrepresentationoftheLVcloningstrategy. ThereisaBamHIclonesiteatthe5’-endoftheoriginalvectorspcDNA3.1/V5-His-Snk/
hPlk2, and pEGFP-N1, respectively. A BamHI clone site was inserted at the 3’-ends of EGFP and hPlk2WT by SDM, respectively. Then, K111M, T239D
andT239VmutantswerecreatedthroughSDMusinghPlk2WTgeneastemplate.TheinsertsweredigestedwithBamHI,andpurified.Atthesametime,
pWPIvectorwasdigestedbyBamHI,andtreatedwithCIPtoprotecttheself-circularizationofthevectorDNA.Finally,LVswereclonedthroughligation
and transformation.
www.nature.com/scientificreports
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sformation efficiency of Top10 could reach up to 1310
9 cfu/mg
supercoiled DNA, whereas, DH5a just about 10
6 cfu/mg supercoiled
DNA (Invitrogen). In addition, we also performed the insertion of
BamH I site at the 3’-end of EGFP using pEGFP-N1 vector as
template. After annealing at 62uC, the mutation efficiency was about
83.5% (Figure 1, Table 2). These data demonstrated that the designed
mutagenesis was successfully achieved.
CIP treatment improved the rates of recombinant vectors. A
unique BamH I site of pWPI/Neo/BamH I LV was employed as a
clonesite.Toprotectthevectorself-circularization,the5’-phosphate
groups of the vector DNA were removed with CIP treatment fol-
lowing BamH I digestion. This treatment could diminish the back-
ground of transformed bacterial colonies that carried empty
plasmids. At the same time, the colony number would be sig-
nificantly decreased after transformation
10,18,19. Insert (EGFP, hPlk2
WT,K111M,T239DandT239V,respectively)andvectorDNAwere
pooled together in 10ml ligation reactions with total DNA
concentrations around 19,30ng/ml, and insert to vector molar
ratios about 1,3.2:1 (Table 4, 5). To improve the transformation
efficiencies, Top10 cells were used for transformation. Four inde-
pendent ligation and transformation experiments were conducted
with Top10 cells (n54, Table 4, 5). Compared with DH5a cells,
more colonies were obtained from Top10 cell transformations,
whereas, a few colonies were gained from three DH5a cell trans-
formations of each, respectively (Table 5). 41 of those colonies
were selected for identification, respectively. The results showed
that the total percentage of recombinant vectors was up to 93.7%
(192/205). Among them, the individual percentages of inserted
vectors of EGFP, hPlk2 WT, K111M, T239D, and T239V, were
97%65.5%, 95%610.5%, 91%610.9%, 95%66.4%, and 93%6
5.2%, respectively (Figure 2, Table 5). The percentages of inserted
vectors between them had no significant differences (P.0.05)
(Table 5). These data demonstrated that the self-ligation of the
vectors was efficiently protected by CIP treatment, and the rates of
recombinant vectors were radically increased.
Efficient construction of LVs with monomeric, correct orien-
tations. After miniprep, the insert number and orientation were
primarily identified by Not I digestion. Because there was a unique
Not I restriction endonuclease site inside pWPI/Neo/BamH I vector
at 1145 nucleotide (nt) and the BamH I clone site at 3502 nt. There
wasalsoaNotIsite atthe 3’-end of EGFP(about 0.75kb). Therefore,
after Not I digestion, if the vector was empty, one band was detected
byAgarosegelelectrophoresis;ifthevectorcontainedonecopyofthe
insert and in correct orientation, two bands of ,3.1 kb and ,9k b
sizes were detected; and if the insert was in opposite orientation, two
bands of ,2.4 kb and ,9.75 kb sizes were detected (Figure 2, A and
B). In addition, within the 5’-BamH I-hPlk2-3’-BamH I fragment
(about2.1kb), therewasaNotIsite at118nt.Therefore, ifthevector
containedonecopyoftheinsertinthecorrectorientation,twobands
of,2.5kband,11kbsizesweredetected;andiftheinsertwasinthe
opposite orientation, two bands of ,4.4 kb and ,9.2 kb sizes were
detected(Figure2,B,C,D,E,F,GandH).Someofthepositiveclones
were further confirmed by sequencing. Our data revealed that the
total percentage of monomeric inserted vectors of EGFP, hPlk2 WT,
K111M, T239D, and T239V, was approximately 90.2% (185/205),
and the individual percentages of those were 93%65.2%, 89%6
12.4%, 88%615.6%, 91%66.2%, and 93%65.2%, respectively. In
addition, the percentages of monomeric inserted vectors between
them had no significant differences (P.0.05) (Table 5). Further-
more, the total percentage of positive clones of EGFP, hPlk2 WT,
K111M, T239D, and T239V, in which monomeric, correct-oriented
inserts were carried, was about 48%67.6%, and the individual
percentages of those were about 37%612.4%, 43%616.6%,
52%621.2%, 54%69.8%, and 54%612.8%, respectively. Finally,
the percentages of positive clones between them were not
significantly different (P.0.05) (Table 5).
As controls, pWPI vector DNA, which was not treated with CIP,
was also used for ligation with the inserts, EGFP, hPlk2WT, K111M,
T239D and T239V, respectively. After transformation into Top10
cells, 10 clones of each were selected for identification. Our results
revealed that, among the 50 clones identified, 5 clones were with
monomeric insert, and one clone of pWPI/hPlk2T239V/Neo was
Table 2 | Mutagenesis efficiency of BamH I insertion and hPlk2 mutants
Mutagenesis
Annealing
Temperature (uC)
Hosts of
transformation
No. of obtained
colonies
No. of sequenced
colonies
Percentageofpositive
colonies
pcDNA3.1/BamH I 59 Top10 13 (n51) 10 90% (9)
pEGFP-N1/BamH I 62 Top10 6 (n51) 6 83.3% (5)
K111M 59 Top10 ,200 (n51) 10 50% (5)
T239D 63 Top10 ,200 (n51) 10 60% (6)
T239V 63 Top10 19 (n51) 10 90% (9)
Note. pcDNA3.1/BamH I: pcDNA3.1/hPlk2WT/ BamH I insertion; pEGFP-N1/BamH I: pEGFP-N1/BamH I insertion; K111M: pcDNA3.1/hPlk2K111M/BamH I; T239D: pcDNA3.1/hPlk2T239D/
BamH I; T239V: pcDNA3.1/hPlk2T239V/BamH I.
Table 1 | Characteristics of mutagenesis primer pairs
Primer name
Length/
mutation (bases) Tm (uC) Tm* (uC)
Hairpin
formation
Self-Dimer
formation
pcDNA3.1/hPlk2 WT/ BamH I insertion forward 48/6 87.9 68.6 No Yes
pcDNA3.1/hPlk2 WT/BamH I insertion complement 48/6 87.9 68.6 No Yes
pEGFP-N1/BamH I insertion forward 44/6 86.7 66.7 No Yes
pEGFP-N1/BamH I insertion complement 44/6 86.7 66.7 No Yes
pcDNA3.1/hPlk2 K111M forward 36/2 76.6 64.1 No Yes
pcDNA3.1/hPlk2 K111M complement 36/2 76.6 64.1 No Yes
pcDNA3.1/hPlk2 T239D forward 51/3 80.9 66.5 No Yes
pcDNA3.1/hPlk2 T239D complement 51/3 80.9 66.5 No Yes
pcDNA3.1/hPlk2 T239V forward 56/2 84.2 66.8 No Yes
pcDNA3.1/hPlk2 T239V complement 56/2 84.2 66.8 No Yes
Note: Tm: primer-to-template annealing temperature, which considered the mismatches of the bases; Tm*: primer-pair self-annealing temperatures.
www.nature.com/scientificreports
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positive clones was 2%64.5% (n55), and when compared with the
CIP-treatedexperimentdata,thedifferencebetweenthemwashighly
significant (2%64.5% vs 48%67.6%, P,0.01).
Transient expression of hPlk2 WT, mutants, and EGFP genes. To
test the function of constructed vectors, four pWPI/hPlk2WT/Neo,
two of each pWPI/K111M/Neo, pWPI/T239D/Neo, pWPI/T239V/
Neo, and pWPI/EGFP/Neo positive clones were randomly chosen
for transient expression in HEK293T cells. The hPlk2 WT and
mutant gene sequences contained a 6xHis tag at their C-termini,
therefore, their expression was tested with Western blotting for the
6xHis tag expression. EGFP transient expression was observed by
fluorescencemicroscopy.Allthevectorswereefficientlyexpressedin
HEK293T cells, 48 hours after transfection (Figure 3).
Discussion
Creation of compatible ends between vectors and inserts is the first
step for cloning. It is critical that the ends of DNA fragments are
correctly generated after restriction digestion, particularly for large-
size, low-efficiency cloning. Regular vectors, such as pcDNA3 and
pcDNA4 (Invitrogen), contain multiple clone sites. Therefore, it is
convenienttochoosetwodifferentclonesitesfordirectionalcloning.
Generally, LVs carry limited clone sites, and a unique clone site is
usually used for cloning, such as BamH I or EcoR V
5,20 etc. The
incorporation of restriction endonuclease sites into the primers for
PCR is a commonly used strategy. But the extra 3-4 bases at the
terminal restriction sites are insufficient for stable association with
and cutting by certain restriction endonucleases. Therefore the clon-
ing efficiencies were very low, for example, as reported #0.05%
11,13.
Anotherstrategy istocreate blunt endsforthe vectorsand/or inserts
with the Klenow fragment of DNA polymerase I or T4 DNA poly-
merase.Thismethodisalsooflowefficiencyduetotworeasons.One
is the low efficiency of blunt end ligation compared with cohesive
ends. The other is the inefficiency of creation of correct blunt ends,
for example, the filling-in efficiency of Klenow was reported as
#50%
14,21,22. In our previous LV vector cloning experiments, blunt
ends were created for the inserts with Klenow and T4 DNA poly-
merasetreatment.Afterdozensofligationsandtransformationswith
Top10cells,nopositivecloneswereobtained(datanotshown).SDM
is a powerful tool to change DNA sequences at specific positions in
genetic engineering, including insertion of restriction sites
16,17,23.
According to the working format of the QuikChange
TM SDM
System, the mutagenesis products after Dpn I digestion and trans-
formation are circular double-stranded plasmid DNA (Stratagene).
Therefore, after restriction digestion, 100% of the purified linearized
DNA fragments through Agarose gel electrophoresis are theoret-
ically with correct ends. Whereas, the correct cutting ends can not
be confirmed with the method of incorporating of restriction sites
intoPCRprimers
11,13.Our datademonstrated that theclone efficien-
ciesweresignificantlyimprovedwiththisstrategy.Thetotalpercent-
age of recombinant clones was about 93.7%, and the percentage of
positivecloneswithmonomeric,correct-orientedinsertswasaround
48%67.6% (Table 5, Figure 2).
Design of the primers is crucial for successful mutagenesis.
According to the guide of the QuikChange
TM SDM System of
Stratagene, complementary primer pairs were employed in the same
PCR. One disadvantage of using complementary primer pairs is the
formation of ‘‘primer dimers’’ in PCR reactions. Therefore the yield
of successful transformants is reduced. This phenomenon is particu-
larly severe in SDM, because the primers used include mismatched
nucleotides for generating the desired mutations
23. Another dis-
advantage of the Stratagene strategy is that the newly synthesized
DNA is ‘‘nicked’’. They cannot be used as templates for subsequent
amplification compared with regular PCR. This constraint also leads
to lower PCR efficiency
17. To circumvent these problems, several
modifications were developed, such as using primers containing
extended non-overlapping sequences at the 3’ end (significantly lar-
ger than suggested in Ref. 24) and primer-primer complementary
sequences at the 5’ end
17, running two PCR reactions in parallel with
each one of the forward and reverse primers
23 and so on. At the
present study, we adopted the classical Stratagene strategy, and
encountered problems in transformation using DH5a cells with its
suggested annealing temperatures. After optimizing the annealing
temperatures (approximately Tm*-5uC), and employing Top10 cells
for transformation, the mutagenesis efficiencies were approximately
90% for pcDNA3.1/hPlk2/BamH I insertion, 83.3% for pEGFP-N1/
BamH I insertion, 50% for K111M mutagenesis, 60% for T239D and
90% for T239V mutagenesis, respectively (Table 1, 2). Furthermore,
compared with DH5a cells, Top10 cells were more applicable for
Table 3 | Mutagenesis efficiencies with different annealing temperatures
Mutagenesis
Hosts of
transformation
Annealing temperature (uC) &
total No. of transformation colonies
No. of identified
colonies
Percentages of
positive mutagenesis
pcDNA3.1/BamH I Top10 83/0 (n51) 70/8 (n51) 4 100% (4/4)
K111M Top10 72/0 (n51) 66/1 (n51) 1 100% (1/1)
T239D Top10 76/0 (n51) 68/0 (n51) 0 0/0
T239V Top10 79/0 (n51) 68/1 (n51) 1 100% (1/1)
Table 4 | ligation reactions of pWPI (CIP-treated) with hPlk2 WT, mutants and EGFP
Experiment No. #1 #2 #3 #4
pWPI [volume (ml), concentration (ng/ml)] 5* (31.8) 2 (98) 2 (124) 2 (107)
EGFP [volume (ml), concentration (ng/ml)] 2 (11.8) 2 (11) 2 (11) 2 (11)
hPlk2WT [volume (ml), concentration (ng/ml)] 3.5 (15.8) 2 (23) 2 (23) 2 (23)
K111M[volume(ml),concentration(ng/ml)] 3.5 (26.8) 2 (26) 2 (26) 2 (26)
T239D [volume (ml), concentration (ng/ml)] 3.5 (16.8) 2 (26) 2 (26) 2 (26)
T239V [volume (ml), concentration (ng/ml)] 3.5 (8.9) 2 (26) 2 (26) 2 (26)
ddH2O( ml) 0 4.5 4.5 4.5
10X T4 DNA ligase buffer (ml) 111 1
T4 DNA ligase (2000U/ml) (ml) 0.5 0.5 0.5 0.5
Note: *6.5 ml for EGFP ligation.
www.nature.com/scientificreports
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formation experiments (Table 5).
Ligation and transformation are complicated procedures. Many
factors can affect their efficiencies, such as the dephosphorylation of
the vectors, the concentrations and ratios of the vector and insert
DNA, the amount of DNA used for transformation, and so on.
Removing the 5’-phosphate residues from both termini of the vector
DNA can efficiently minimize the re-circularization of vector DNA
(Figure1),andtherefore,decreasethebackgroundwithemptytrans-
formants.Inourexperiment, aunique BamHIsitewasusedasclone
site (Figure 1), and the total percentage of recombinant clones after
CIP treatment of the vector was up to about 93.7%. Our data were
consistent with other reports
18,19. The difference of clone efficiencies
betweennon-CIP treatedvectors andCIP-treated vectors washighly
significant (2%64.5% VS 48%67.6%, P,0.01). Some reports
recommend that DNA concentration of ligation is about 10 ng/ml,
the ratio of insert to vector DNA can be around 1 to 1, and the
transformation volumes are less than 10% of the competent cells
10,25.
Considering these recommendations, we used around 19,30 ng/ml
DNA,lowinserttovectormolarratios(1,3.2:1)forligation,and2ml
(about 38–60 ng) volume of the ligation products for transforma-
tion. We found that these optimizations resulted in high efficiencies
fortheconstructionofLVswithmonomeric,correct-orientedinserts
(Table 5).
Compared with ligation-independent cloning strategies, such as
the In-Fusion method
28, here we report an efficient ligation-depend-
ent method to construct LVs, which circumvents the barriers for
efficient cloning of large-size vectors. Firstly, creation of clone site
bySDMguaranteedthat100%ofthelinearizedDNAfragmentswere
with correct cutting-ends. Secondly, dephosphorylation of vector
DNA confirmed that most of the transformants (93.7%) were with
recombinants. Thirdly, optimization of the amount and ratio of the
insert and vector DNA increased the rate of monomeric, correct-
oriented recombinants (48%67.6%). Finally, Top10 cells improved
the transformation efficiencies, and therefore facilitated sufficient
colonies for identification. As a result, five bicistronic LVs were
successfully constructed. These vectors were efficiently expressed
in HEK293T cells after transfection (Figure 3). pWPI/hPlk2WT/
NeoandpWPI/hPlk2K111M/Neovectorswerefurtherusedtoinfect
neural progenitor cells for stable expression expreiments
26. This
study provided an important quantitative method for cloning
large-size vectors, and furthermore, accelerated the establishment of
in vitro gain-of-function models for gene function analyses.
Methods
Design of SDM primers. Two-step SDM strategies were performed to sequentially
insert BamH I sites for plasmids pcDNA3.1/V5-His-Snk/hPlk2
27 (pcDNA3.1/hPlk2,
Addgene plasmid 16015) and pEGFP-N1 (Clontech) at the 3’-end of hPlk2WT and
EGFP open reading frames, respectively, and then create hPlk2 mutants: K111M,
T239D, and T239V with pcDNA3.1/V5-His-Snk/hPlk2WT/BamH I as template
(Figure 1). All primers were designed according to the guide of Stratagene’s
QuickChange
TMSDMkit,synthesizedandpurifiedbyIntegratedDNATechnologies.
For all primers, mutagenized positions were denoted in lower case and underlined.
pcDNA3.1/hPlk2 WT/ BamH I insertion forward: 5’-CATCATCACCATCACC-
ATTGAggatccGTTTAAACCCGCTGATCAGCC-3’;
pcDNA3.1/hPlk2 WT/BamH I insertion complement: 5’-
GGCTGATCAGCGGGTTTAAACggatccTCAATGGTGATGGTGATGATG-3’;
pcDNA3.1/hPlk2 K111M/BamH I forward: 5’-
CAAAGTCTACGCCGCAAtgATTATTCCTCACAGCAG-3’;
pcDNA3.1/hPlk2 K111M/BamH I complement: 5’-
CTGCTGTGAGGAATAATcaTTGCGGCGTAGACTTTG-3’;
pcDNA3.1/hPlk2 T239D/BamH I forward: 5’-GAACCCTTGGAACACAGAAG-
GAGAgacATATGTGGTACCCCAAATTATCTC-3’;
pcDNA3.1/hPlk2 T239D/BamH I complement: 5’-
GAGATAATTTGGGGTACCACATATgtcTCTCCTTCTGTGTTCCAAGGGTTC-
3’;
pcDNA3.1/hPlk2 T239V/BamH I forward: 5’-CTAGAACCCTTGGAACACAG-
AAGGAGAgtGATATGTGGTACCCCAAATTATCTCTC-3’;
pcDNA3.1/hPlk2 T239V/BamH I complement: 5’-GAGAGATAATTTGGGGTA-
CCACATATCacTCTCCTTCTGTGTTCCAAGGGTTCTAG-3’;
pEGFP-N1/BamH I insertion forward: 5’-GTACAAGTAAAGCGGCCGCggatcc-
GACTCTAGATCATAATCAG-3’;
pEGFP-N1/BamH I insertion complement: 5’-CTGATTATGATCTAGAGTCggatcc-
GCGGCCGCTTTACTTGTAC-3’.
The melting temperatures (Tm, primer-to-template annealing temperature) and
primer-pair self-annealing temperatures (Tm*) were calculated by Stratagene Quik-
change Primer Tm Calculator (http://www.stratagene.com/QPCR/tmCalc.aspx), and
Integrated DNA Technologies SciTools OligoAnalyzer 3.1 (http://www.idtdna.com/
analyzer/applications/oligoanalyzer/default.aspx), respectively (Table 1). Hairpin and
self-dimer formation of the primers were analyzed by Integrated DNA Technologies
SciTools OligoAnalyzer 3.1 as well (Table 1). All the DNA preparation kits, including
Miniprep, Maxiprep, and Gel extraction kits, were purchased from QIAGEN. The
DNA purities used in experiments were tested by NanoDrop-1000 Spectrophotometer
(NanoDrop Technologies), and all the A260/280 values were $ 1.80.
Mutagenesis. The PCR reactions were carried out with GeneAmpH PCR System 2700
(ABAppliedBiosystems). The50ml PCRreactionwascarried outwith50ngtemplates,
125 ng of each forward and complement primers, 20mM of each dNTP (Invitrogen),
2.5 U of PfuUltra DNA polymerase, in 1 X reaction buffer (Stratagene). The thermal
cycler programs for amplifications were as follows: denaturation at 94uC for 2 min; 18
cycles at 94uC for 30 sec, annealing for 30 sec, at 59uC for pcDNA3.1BamH I insertion
Table 5 | Construction efficiencies of lentiviral vectors with CIP-treated vector DNA
Vector
Molar ratio &
concentration of
inserts/vector
Hosts of
transformation
Total No. of
transformed
colonies
Total No.
of identified
colonies
Percentage of
inserted vectors
(Mean6SD)
Percentage of
monomeric inserted
vectors (Mean6SD)
Percentage of
Correct-oriented
inserts
(Mean6SD)
EGFP 1.3,1.7 : 1( n 54)
(21.8,27.0ng/ml)
Top10/DH5a 1496100
(n54)
a /2
a
(n53)
41 (n54)
/2 (n51)
97%65.5%
a
(40) /100% (2)
93%65.2%
a
(38) /100% (2)
37%612.4%
a
(16) /0 (0)
hPlk2 WT 1.1,1.8 : 1( n 54)
(21.4,29.4ng/ml)
Top10/DH5a 1236108
(n54)
a /1
a
(n53)
41 (n54)
/1 (n51)
95%610.5%
a
(38) /100% (1)
89%612.4%
a
(36) /100% (1)
43%616.6%
a
(17) /100% (1)
K111M 1.2,3.2 : 1( n 54)
(24.8,30.0ng/ml)
Top10/DH5a 123688
(n54)
a /3
a
(n53)
41 (n54)
/3 (n51)
91%610.9%
a
(37) /100% (3)
88%615.6%
a
(36) /100% (3)
52%621.2%
a
(21) /66.7% (2)
T239D 1.2,2 : 1( n 54)
(21.8,30.0ng/ml)
Top10/DH5a 126678
(n54)
a /7
a
(n53)
41 (n54)
/6 (n51)
95%66.4%
a
(39) /100% (6)
91%66.2%
a
(37) /100% (6)
54%69.8%
a
(22) /83.3% (5)
T239V 1,1.5 : 1( n 54)
(19.0,30.0ng/ml)
Top10/DH5a 98660
(n54)
a /4
a
(n53)
41 (n54)
/4 (n51)
93%65.2%
a
(38) /100% (4)
93%65.2%
a
(38) /100% (4)
54%612.8%
a
(23) /100% (4)
Note: Data in boldfaces are obtained from Top10 cell transformation. Percentage of inserted vectors5No. of inserted vectors/total No. of identified colonies; Percentage of monomeric inserted
vectors5No. of monomeric inserted vectors/total No. of identified colonies; Percentage of positive colonies5No. of vectors with monomeric correct-oriented insert/total No. of identified colonies.
aValues in the same column indicates no significant difference (P.0.05); EGFP: pWPI/EGFP/Neo; hPLK2WT: pWPI/hPlk2WT/Neo; K111M: pWPI/hPlk2K111M/Neo; T239D: pWPI/hPlk2T239D/
Neo; T239V: pWPI/hPlk2T239V/Neo.
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N1 BamH I insertion, respectively (Table 2), and at 72uC for 8 min for pcDNA3.1/
hPlk2 template, 5 min for pEGFP-N1 template; followed by a final extension at 72uC
for 10 min. When the amplifications were finished, 1 ml (10 U) of Dpn I (Stratagene)
was added into each reaction, and incubated at 37uC for 1 hour. Finally, 1 ml reaction
products were used for transformation into 50 mlD H 5 a or Top10 competent cells
(Invitrogen), respectively, according to the manufacturer’s guides. All the
transformants were used to spread plates. Transformation colonies were selected and
their plasmids were isolated by Miniprep, and the positive mutants were identified by
sequencing.
Preparation ofvectorandinsertDNA.ThebicistronicLVpWPI(Addgeneplasmid
12254) was modified by creating a BamH I site at 3502 nt and replacing EGFP
sequence with Neo, to form pWPI/Neo/BamH I. pWPI/Neo/BamH I DNA was
digested with BamH I (NEW ENGLAND BioLabs), then divided into two aliquots,
one aliquot of the vector DNA was used directly for ligation, and another aliquot was
treated with CIP (NEW ENGLAND BioLabs) to remove the 5’-phosphate groups
10
(Figure1)asfollows:ina300mlreaction,containingdigestedpWPI/NeoDNA(about
15 mg), 50 U CIP in 1 X NEBuffer 3, at 37uC water bath for 1 hours. Both aliquots of
pWPI/Neo vector DNA (CIP-treated and not treated) were purified by 1% Agarose
gelelectrophoresis,andrecovered byQIAGENGelExtractionKit.pcDNA3.1/BamHI
plasmids, carrying hPlk2 WT and mutants K111M, T239D, and T239V, respectively,
and plasmid pEGFP-N1/BamH I were digested with BamH I. Then the inserts, hPlk2
WT, K111M, T239D, T239V and EGFP, were recovered by 1% Agarose gel electro-
phoresis and gel extraction procedure, respectively.
Ligation. To achieve the molar ratios of inserts to vector about 1,3.2:1, the ligation re-
actions were set up according to Table 4. In 10ml ligation systems, at first, the vector and
insert were pooled together, warmed at 45uC for 5 min to melt any cohesive termini that
had re-annealed during fragment preparation, then chilled on ice for 2 min, and then li-
gated with 0.5ml (1000 U) high-concentration T4 DNA ligase (NEW ENGLAND BioLabs)
in 1 X T4 DNA ligase buffer (Figure 1). The 10ml reaction mixtures were incubated in
GeneAmpHPCR System 2700 at 16uC for 16 hours followed by inactivation at 65uCf o r1 0
min, and then set at 4uC until transformation
10.
Transformation and identification. 2ml (about 38,60 ng) volumes of the ligation
productswereusedtotransform50mlofDH5aandTop10 competentcellsaccording
to the manufacturer’s instructions (Invitrogen, Table 5). Briefly, the ligation reaction
tubes were centrifuged briefly and placed on ice. One 50ml vial of One ShotH Top10
cellsorDH5acellswasthawedonicefor30minforeachligation/transformation.2ml
of each ligation reaction were added directly into the vial of competent cells and
mixedbytappinggentlyratherthanpipettingupanddown.Thevialswereincubated
on ice for 30 min. Then, Top10 cells were incubated for exactly 30 seconds in a 42uC
water bath, but for DH5acells, 20 seconds were used without shaking. The vials were
Figure 2 | Agarose gelelectrophoresis foridentificationofconstructed vectorsdigested byNot I(threeindependent experiments, n53). A.lanes1–9,
10–18,andB,lanes1–9:pWPI/EGFP/Neo.A,lanes#2,4,6,7,10,11,15,andB.lanes#4,and5,werepositivewithcorrectorientation;A.lanes#1,3,5,8,
9,12,13,16,17,18,andB,lanes#1,3,6,7,8,and9,werenegativewithoppositeorientation.LaneM:GeneRuler
TM1kbDNALadderPlus(Fermentas).B.
lanes 10–18, andC, lanes 1–9, 10–18:pWPI/hPlk2WT/Neo. B, lanes #10, 13, 16, 17, 18, and C, lanes #1, 5,6, 8, 9, 10, and 17, were positive with correct
orientation;B,lanes#11,12,14,15,andC.lanes#2,3,4,7,12,13,14,16,and18,werenegativewithoppositeorientation.D.lanes1–9,10–18andE,lanes
1–9:pWPI/hPlk2K111M/Neo.D,lanes#5,8,11,13,14,15,16,18,andE,lanes#1,2,6,7,8,and9,werepositivewithcorrectorientation;D.lanes#1,4,7,
9,10,12,17,andE.lanes#3,4,5,werenegativewithoppositeorientation.E,lanes10–18,andF,lanes1–9,10–18:pWPI/hPlk2T239D/Neo.E.lanes#10,
11,13,15,16,18,andF.lanes#1,4,5,8,9,10,11,12,18,werepositivewithcorrectorientation;E.lanes#12,14,17,andF,lanes#3,6,7,13,14,15,16,were
negativewithoppositeorientation.G.lanes1–9,10–18andH.lanes1–9:pWPI/hPlk2T239V/Neo.G.lanes#1,5,6,9,11,12,13,17,18,andH,lanes#1,
2, 5, 6, were positive with correct orientation; G. lanes #2, 4, 7, 8, 14, 15, 16, and H. lanes #3, 4, 7, 8, 9, were negative with opposite orientation.
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S.O.Cmedium (Invitrogen)wereadded toeachvial, andthe vials wereshook at37uC
forexactly1hourat225rpminashakingincubator.Inordertoobtainmorecolonies,
allthetransformationcellswereusedtospreadplates.Aftertheplatesweredried,they
were inverted and incubated at 37uC overnight. Positive colonies were primarily
analyzed by Not I (NEW ENGLAND BioLabs) digestion. And some of them were
further confirmed by DNA sequencing.
Cell culture and transfection. HEK293T cells were thawed from liquid nitrogen and
culturedinDulbecco’smodifiedeaglemedium(DMEM)containing10%fetalbovine
serum(FBS)(WisentBiocenter)foraweekin10-cmdishes.6-wellplateswerecoated
with 0.001% poly-L-lysine (Sigma) for 15 minutes at room temperature
29. When
HEK293T cells were split, the cells were washed with Ca
21,M g
21-free DPBS twice
(WisentBiocenter),thentreated with 0.25%Trypsin-EDTA (Wisent Biocenter)for 1
min at room temperature, and then pipetted up and down several times to separate
them into single cells. In order to obtain even distribution of the cells across the
surfaceoftheplates,thecellswereswirledthoroughlybeforeseeding
29.Whenthecells
were 50–70% confluent, transfection was performed with LipofectamineH 2000
accordingtothemanufacturer’sguide(Invitrogen).Briefly,foreachtransfection,4mg
DNA of pWPI/hPlk2WT/Neo, pWPI/hPlk2K111M/Neo, pWPI/hPlk2T239D/Neo,
pWPI/hPlk2T239V/Neo, and pWPI/EGFP/Neo, respectively, was diluted in 250ml
DMEM medium (without FBS), mixed thoroughly by low-speed vortex. 10ml
Lipofectamine 2000 was diluted in 250ml DMEM, mixed gently by inversion, and
incubated for 5 min at room temperature. The diluted DNA and Lipofectamine 2000
were combined, mixed gently by inversion, and incubated for 20 min at room
temperature to form Lipofectamine-DNA complexes. Finally, the 500ml complexes
were added to each well containing HEK293T cells and 2 ml DMEM 1 10% FBS
medium, mixed gently by rocking the plates. The cells were incubated at 37uCi na
CO2 incubator for 6 hours or overnight. The medium was replenished with fresh
DMEM 1 10% FBS medium. 48 hours after transfection, the cells were collected for
Western blotting to test the transgene expression.
Western blotting. Cell lysates were prepared in cell lysis buffer (50 mM Tris, pH8.3,
150 mM NaCl, 1% NP-40, 1% Sodium deoxycholate, and 1 X Protease inhibitor
cocktail (Sigma)). Briefly, cell culture medium was removed from 6-well plates, and
washed with ice-cold DPBS twice. Then 300ml lysis buffer was added into each well,
incubated on ice for 10 min. 75ml 5 X Laemmli buffer (312.5 mM Tris-HCl, pH6.8,
10% SDS, 250 mM DTT, 50% Glycerol, and 0.05% Bromophenol blue) was added
intoeach tube,mixed and heated at 95uCfor 10min. Finally,the samples werestored
at 280uC until running SDS-PAGE.
10%, 1.0 mm SDS-PAGE gels were run to separate the sample proteins. 10mlo f
BenchMark
TM prestained protein ladder (Invitrogen), and 20mlo fe a c hs a m p l ew e r e
loaded. HEK293T cell lysate was used as negative controls for the transgene express-
ion. The gels were run in 1XTris-glycine SDS buffer (Bioshop). The proteins were
transferred onto nitrocellulose and processed for Western blotting, and protein bands
were visualized with ECL-plus Western blotting detection system (GE Healthcare).
Antibodies used in this study included: mouse anti-tetraHIS primary antibody
(1:2000 dilution) (Qiagen), mouse anti-glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) primary antibody (1:2000 dilution) (Sigma). The goat anti-mouse sec-
ondary antibody was ImmunopureH goat anti-mouse IgG, H1L, Peroxidase con-
jugated,purchasedfromThermoScientific.Goatanti-mousesecondaryantibodywas
1:2500 diluted for probing tetraHIS expression, and 1:8000 diluted for GAPDH
expression. All the antibodies were diluted in Tris buffered saline (TBS, Wisent
Biocenter) with 0.05% Tween-20 and 5% milk.
Fluorescence microscopy. A Axiovert 100TV (Zeiss) fluorescence microscope
equipped with a AttoArc
TM HBO 100W (Carl Zeiss) lamp power supply was used to
observe the transient expression of EGFP in HEK293T cells, 48 hours after
transfection. Microscopic images were photographed using a digital camera (Kodak
DC290 ZOOM).
Data Statistics. Data were analyzed by Mean6SD and Student’s t-Test.
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